Leo C. H. Tsang

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “Comparative antibody and cell-mediated immune responses, reactogenicity, and efficacy of homologous and heterologous boosting with CoronaVac and BNT162b2 (Cobovax): an open-label, randomised trial”.

Comparative antibody and cell-mediated immune responses, reactogenicity, and efficacy of homologous and heterologous boosting with CoronaVac and BNT162b2 (Cobovax): an open-label, randomised trial

The Lancet Microbe(2023)10.1016/s2666-5247(23)00216-1

N/A

0.749DataRank · unranked

25 citations

Samuel M. S. Cheng, Carolyn A. Cohen, Mario Martín-Sánchez, Niki Y. M. Au, Leo L. H. Luk +17 more

Neutralizing antibodies against the SARS-CoV-2 Omicron variant BA.1 following homologous and heterologous CoronaVac or BNT162b2 vaccination

Nature Medicine(2022)10.1038/s41591-022-01704-7

N/A

0DataRank · unranked

374 citations

Chris Ka Pun Mok, Yonna W. Y. Leung, Susanna S. Ng, Kaimin Chan, Fanny W.S. Ko +12 more

SARS-CoV-2 Omicron variant BA.2 neutralisation in sera of people with Comirnaty or CoronaVac vaccination, infection or breakthrough infection, Hong Kong, 2020 to 2022

Eurosurveillance(2022)10.2807/1560-7917.es.2022.27.18.2200178

N/A

0DataRank · unranked

36 citations

Chris Ka Pun Mok, Karl CK Chan, Susanna S. Ng, Bosco HS Lam, Leo L. H. Luk +10 more

Neutralizing antibody titres to SARS-CoV-2 Omicron variant and wild-type virus in those with past infection or vaccinated or boosted with mRNA BNT162b2 or inactivated CoronaVac vaccines

Research Square(2022)10.21203/rs.3.rs-1207071/v1

N/A

0DataRank · unranked

27 citations

Samuel M. S. Cheng, Chris Ka Pun Mok, Yonna W. Y. Leung, Susanna S. Ng, Karl CK Chan +12 more

Homologous and heterologous boosting with CoronaVac and BNT162b2: a randomized trial (the Cobovax study)

medRxiv(2022)10.1101/2022.08.25.22279158

N/A

0DataRank · unranked

4 citations

Samuel M. S. Cheng, Carolyn A. Cohen, Mario Martín-Sánchez, Niki Y. M. Au, Leo L. H. Luk +17 more

Virus neutralization of SARS-CoV-2 Omicron variant BA.2 in those vaccinated with three doses of BNT162b2 or CoronaVac vaccines.

Research Square(2022)10.21203/rs.3.rs-1331606/v1

N/A

0DataRank · unranked

3 citations

Samuel M. S. Cheng, Karl CK Chan, Leo L. H. Luk, John Li, Leo C. H. Tsang +10 more